Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00602355 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of Sertraline Alone and Interpersonal Psychotherapy Alone in Treating Women With Postpartum Depression
A Phase 2 study of Depression, Postpartum, sponsored by Women and Infants Hospital of Rhode Island.
- Completed
- Registry status
- Phase 2
- Development phase
- 162
- Enrollment target
- 2
- Study locations
NCT00602355 is a Phase 2 study of Depression, Postpartum that has completed, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 162 participants, roughly in line with the 153-participant average among 15 other Depression, Postpartum trials with a reported enrollment target. The trial reports 2 study locations across 2 states.
The verdict
NCT00602355, a Phase 2 study of Depression, Postpartum, has completed, sponsored by Women and Infants Hospital of Rhode Island.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 162 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will evaluate the effectiveness of antidepressant medication alone and interpersonal psychotherapy alone in treating women with postpartum depression.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Sertraline
- BEHAVIORAL Interpersonal psychotherapy (IPT)
- BEHAVIORAL Clinical management
- BEHAVIORAL Mothercrafting
Study Locations (2)
Iowa
- University of Iowa - Iowa City
Rhode Island
- Women and Infants Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2008-02 |
| Est. Completion | 2014-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00602355
The ClinicalTrials.gov registry entry for NCT00602355 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 153-participant average among 15 other Depression, Postpartum trials with a reported enrollment target. The listed sponsor is Women and Infants Hospital of Rhode Island, which has 65 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Depression, Postpartum appearing as the primary indexed condition, and to 5 interventions - of which Placebo is the first listed.
NCT00602355 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Iowa, Rhode Island.
Frequently Asked Questions
What is clinical trial NCT00602355 about?
NCT00602355 is a clinical study titled "Effectiveness of Sertraline Alone and Interpersonal Psychotherapy Alone in Treating Women With Postpartum Depression". This study will evaluate the effectiveness of antidepressant medication alone and interpersonal psychotherapy alone in treating women with postpartum depression.
What is the current status of trial NCT00602355?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 162 participants. The study started on 2008-02. Estimated completion is 2014-07.
What conditions does trial NCT00602355 study?
This clinical trial studies the following conditions: Depression, Postpartum.
What interventions are being tested in trial NCT00602355?
The interventions under investigation include: Placebo (DRUG), Sertraline (DRUG), Interpersonal psychotherapy (IPT) (BEHAVIORAL), Clinical management (BEHAVIORAL), Mothercrafting (BEHAVIORAL).
Who is sponsoring clinical trial NCT00602355?
This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00602355 being conducted?
This trial has 2 study locations across Iowa, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression, Postpartum
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
-
Inhaled Oxytocin and HPA Axis Reactivity
COMPLETED · Phase 2
-
A Study to Assess the Efficacy, Safety, and Tolerability of Oral NORA520 in Adults With Severe Postpartum Depression
COMPLETED · Phase 2
-
IMAGINE: Pilot Trial of a Digital Group Intervention to Prevent Perinatal Depression
RECRUITING · NA
-
A Study to Learn More About How Zuranolone Affects Postpartum Depression Symptoms in Participants Who Took it Within 1 Year After The End of Their Pregnancy
RECRUITING
-
HeartGPS: A Study Exploring the Effects of a Psychological Intervention for Parents and Their Babies After Prenatal Cardiac Diagnosis
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.